(+1) 88 700 600
310 West 14th North Street, NY

The Team

Exceptional science attracts leading researchers, collaborators, and business leaders—experts who are able and eager to improve human health and enrich life on this planet. At Viotika Life Sciences, we have assembled such a team, including:

https://viotika.com/wp-content/uploads/2022/10/Chuck-091-640x778.jpg

Charles (Chuck) LaFlèche, FCPA, FCMA

President, Chief Executive Officer, and Chief Financial Officer
Winnipeg, Manitoba

Experienced entrepreneur, CEO, and finance leader with experience in health informatics software, life sciences, aquaculture, and non-profit enterprises.

Dominic Ryan headshot

Dr. Dominic Ryan

Chief Scientific Officer
Littleton, Massachusetts

Seasoned CSO with significant experience in large pharma and biotech research.

© Keith Berr Productions, Inc.
216.566.7950
www.keithberr.com
All Rights Reserved

Dr. Peter Bernstein

Medicinal Chemist
Philadelphia, Pennsylvania

A respected Medicinal Chemist and thought leader with over 30 years of experience in drug development.

https://viotika.com/wp-content/uploads/2023/10/Tom.jpg

Dr. Tom Dougherty

Scientific Advisor
Ayer, Massachusetts

A leading expert in AMR and Neisseria gonorrhea, and a former Research Scientist, Department of Microbiology, at Harvard Medical School.

https://viotika.com/wp-content/uploads/2022/10/download-4.png

Dr. Blanca Barquera

Researcher and NQR Expert
Troy, New York

A Professor of Biological Sciences at Rensselaer Polytechnic Institute, and a leading expert in NQR, the protein at the centre of Viotika’s work.

https://viotika.com/wp-content/uploads/2022/10/Rita-Groleau-1-1.jpeg

Rita Groleau

Winnipeg, Manitoba
Administrative Assistant

Over 30 years of administrative leadership experience in banking, software, and the non-profit sector.

Viotika has entered into a strategic partnership with Evotec SE (https://www.evotec.com/en), a German-based contract research organization that will provide a 10-person science team to advance the work and prepare for animal trials and market entry. Evotec operates in six countries and has established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development.

Strategic Partners

https://viotika.com/wp-content/uploads/2022/10/Evotec.png
https://viotika.com/wp-content/uploads/2022/10/logo211.png
https://viotika.com/wp-content/uploads/2022/10/43f2b7ed03de86175013c2a967c7dd99.jpeg
https://viotika.com/wp-content/uploads/2022/10/download-5.png
https://viotika.com/wp-content/uploads/2022/10/logo-1.png
https://viotika.com/wp-content/uploads/2022/10/site-logo.jpg
https://viotika.com/wp-content/uploads/2022/10/logo12.svg